文献速递慢性肾脏病

慢性肾脏病与老年人主要出血事件的关联:来自阿司匹林减少老年人事件随机试验的数据

Association Between CKD and Major Hemorrhage in Older Persons: Data From the Aspirin in Reducing Events in the Elderly Randomized Trial.
PubMed 文献 · Kidney Int Rep · 2023-01-19

本研究基于阿司匹林减少老年人事件随机试验的双盲随机对照数据,纳入19114名70岁及以上参与者,其中17976人记录了慢性肾脏病状态,4952人(27.5%)患有慢性肾脏病。结果显示慢性肾脏病与主要出血事件风险独立相关(校正后HR 1.37;95%CI 1.15,1.62;P<0.001),且阿司匹林对出血的影响不因慢性肾脏病状态而不同(交互作用检验P=0.65)。

要点

  • 慢性肾脏病与主要出血事件风险独立相关,校正后HR为1.37。
  • 慢性肾脏病组主要出血事件发生率为10.4/1000人年,无慢性肾脏病组为6.3/1000人年。
  • 阿司匹林对出血的影响不因慢性肾脏病状态而存在差异(交互作用P=0.65)。

核心结论

  • 慢性肾脏病与老年人主要出血事件风险增加独立相关。
  • 作者认为需要提高对该人群中可干预危险因素(如停用不必要的阿司匹林、控制血压和戒烟)的认识。

研究设计与样本

  • 研究使用了阿司匹林减少老年人事件随机试验的数据,该试验为双盲随机对照试验,纳入70岁及以上人群,前瞻性捕获出血事件,包括出血性卒中和临床显著出血。
  • 慢性肾脏病定义为估算肾小球滤过率(eGFR)<60 ml/min/1.73 m²和/或尿白蛋白与肌酐比值(UACR)≥3 mg/mmol(26.6 mg/g)。
  • 在19114名参与者中,17976人(94.0%)记录了慢性肾脏病状态,其中4952人(27.5%)患有慢性肾脏病。

主要发现

  • 慢性肾脏病组主要出血事件发生率为10.4/1000人年,无慢性肾脏病组为6.3/1000人年。
  • eGFR<60 ml/min/1.73 m²对应的出血风险比(RR)为1.60(95%CI 1.40,1.90);白蛋白尿对应的RR为2.10(95%CI 1.70,2.50)。
  • 校正分析中,慢性肾脏病与出血风险增加35%相关(HR 1.37;95%CI 1.15,1.62;P<0.001)。
  • 其他危险因素包括年龄较大、高血压、吸烟和阿司匹林使用。
  • 阿司匹林对出血的影响不因慢性肾脏病状态而存在差异(交互作用检验P=0.65)。

关键数值与推荐

  • 慢性肾脏病定义为eGFR<60 ml/min/1.73 m²和/或UACR≥3 mg/mmol(26.6 mg/g)。

临床怎么用

  • 作者认为需要提高对该人群中可干预危险因素(如停用不必要的阿司匹林、控制血压和戒烟)的认识。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Data on the association between chronic kidney disease (CKD) and major hemorrhage in older adults are lacking. METHODS: We used data from a double-blind randomized controlled trial of aspirin in persons aged ≥ 70 years with prospective capture of bleeding events, including hemorrhagic stroke and clinically significant bleeding. CKD was defined as an estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2 and/or urinary albumin-to-creatinine ratio (UACR) ≥ 3 mg/mmol (26.6 mg/g). We compared bleeding rates in those with and without CKD, undertook multivariable analyses, and explored effect modification with aspirin. RESULTS: Of 19,114 participants, 17,976 (94.0%) had CKD status recorded, of whom 4952 (27.5%) had CKD. Participants with CKD had an increased rate of major bleeding events compared with those without CKD (10.4/1000 vs. 6.3/1000 person-years [py], respectively) and increased bleeding risk (risk ratio [RR] 1.60; 95% confidence interval [CI]: 1.40, 1.90 for eGFR < 60 ml/min per 1.73 m2) and RR (2.10; 95% CI: 1.70, 2.50) for albuminuria. In adjusted analyses, CKD was associated with a 35% increased risk of bleeding (hazard ratio [HR] 1.37; 95% CI: 1.15, 1.62; P < 0.001). Other risk factors were older age, hypertension, smoking, and aspirin use. There was no differential effect of aspirin on bleeding by CKD status (test of interaction P = 0.65). CONCLUSION: CKD is independently associated with an increased risk of major hemorrhage in older adults. Increased awareness of modifiable risk factors such as discontinuation of unnecessary aspirin, blood pressure control, and smoking cessation in this group is warranted.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Mahady SE, Polekhina G, Woods RL, et al. Association Between CKD and Major Hemorrhage in Older Persons: Data From the Aspirin in Reducing Events in the Elderly Randomized Trial. Kidney Int Rep. 2023. PMID: 37069989. doi:10.1016/j.ekir.2023.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。